FULVESIDE

Fulvestrant is a Hormonal medication used to treat hormone receptor-positive metastatic breast cancer. It is prescribed as Mono-therapy, combination therapy, and adjuvant therapy. Fulvestrant is a type of estrogen receptor antagonist and selective estrogen receptor degrader (SERD), which works by blocking the activity of estrogen in the body. Hormone receptor-positive breast cancer is characterized by the presence of estrogen and/or progesterone receptors on the surface of cancer cells, which allow the cancer cells to grow and multiply in response to these hormones